✦ LIBER ✦

Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease

✍ Scribed by Pierre Tariot, Steven Salloway, Jane Yardley, Joan Mackell, Margaret Moline

Book ID: 119912685
Publisher: BioMed Central
Year: 2012
Tongue: English
Weight: 197 KB
Volume: 5
Category: Article
ISSN: 1756-0500
DOI: 10.1186/1756-0500-5-283

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term safety and tolerability of don

Long-term safety and tolerability of donepezil 23 mg in patients with moderate-to-severe Alzheimer's disease: An 18-month analysis

✍ Farlow, Martin; Richardson, Sharon; Mackell, Joan; Sun, Yijun 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving

The safety and tolerability of donepezil

The safety and tolerability of donepezil in patients with Alzheimer's disease

✍ Stephen Jackson; Richard J. Ham; David Wilkinson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

Progressive cholinergic decline in Alzhe

Progressive cholinergic decline in Alzheimer's Disease: consideration for treatment with donepezil 23 mg in patients with moderate to severe symptomatology

✍ Marwan Sabbagh; Jeffrey Cummings 📂 Article 📅 2011 🏛 BioMed Central 🌐 English ⚖ 147 KB

Efficacy and Safety of Donepezil 23 mg v

Efficacy and Safety of Donepezil 23 mg versus Donepezil 10 mg for Moderate-to-Severe Alzheimers Disease: A Subgroup Analysis in Patients Already Taking or Not Taking Concomitant Memantine

✍ Doody, Rachelle S.; Geldmacher, David S.; Farlow, Martin R.; Sun, Yijun; Moline, 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 458 KB

Effects of donepezil 23 mg on Severe Imp

Effects of donepezil 23 mg on Severe Impairment Battery domains in patients with moderate to severe Alzheimer’s disease: evaluating the impact of baseline severity

✍ Ferris, Steven; Cummings, Jeffrey; Christensen, Daniel; Doody, Rachelle; Farlow, 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 286 KB